Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic ArthritisJurgen Sota, Luca Cantarini, Claudia Fabiani et al.|Frontiers in Pharmacology|2019Cited by 616
Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter surveyAndrea Taddio, Marco Cattalini, Sara Della Paolera et al.|Pediatric Rheumatology|2021Cited by 126
Development and initial validation of a composite disease activity score for systemic juvenile idiopathic arthritisJessica Tibaldi, Nicolino Ruperto, Angela Pistorio et al.|Lara D. Veeken|2020Cited by 66
Elicitation of Expert Prior Opinion: Application to the MYPAN Trial in Childhood Polyarteritis NodosaLisa V. Hampson, Paul Brogan, John Whitehead et al.|PLoS ONE|2015Cited by 51
Development and Testing of Reduced Versions of the Manual Muscle Test-8 in Juvenile DermatomyositisSilvia Rosina, Angelo Ravelli, Giulia Varnier et al.|The Journal of Rheumatology|2020Cited by 27